Fennec Pharmaceuticals Inc (FENC)
4.72
+0.08
(+1.72%)
USD |
NASDAQ |
Nov 21, 16:00
4.72
0.00 (0.00%)
After-Hours: 20:00
Fennec Pharmaceuticals Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 28, 2024 | 55.39 |
| June 27, 2024 | 55.75 |
| June 26, 2024 | 54.57 |
| June 25, 2024 | 56.20 |
| June 24, 2024 | 57.56 |
| June 21, 2024 | 58.20 |
| June 20, 2024 | 59.29 |
| June 18, 2024 | 60.28 |
| June 17, 2024 | 61.73 |
| June 14, 2024 | 61.28 |
| June 13, 2024 | 62.37 |
| June 12, 2024 | 62.28 |
| June 11, 2024 | 65.72 |
| June 10, 2024 | 64.36 |
| June 07, 2024 | 62.19 |
| June 06, 2024 | 62.10 |
| June 05, 2024 | 60.74 |
| June 04, 2024 | 60.55 |
| June 03, 2024 | 61.01 |
| May 31, 2024 | 61.46 |
| May 30, 2024 | 62.10 |
| May 29, 2024 | 64.82 |
| May 28, 2024 | 63.73 |
| May 24, 2024 | 60.74 |
| May 23, 2024 | 62.28 |
| Date | Value |
|---|---|
| May 22, 2024 | 65.18 |
| May 21, 2024 | 64.54 |
| May 20, 2024 | 66.27 |
| May 17, 2024 | 63.82 |
| May 16, 2024 | 64.54 |
| May 15, 2024 | 63.27 |
| May 14, 2024 | 66.54 |
| May 13, 2024 | 90.83 |
| May 10, 2024 | 88.38 |
| May 09, 2024 | 85.38 |
| May 08, 2024 | 84.02 |
| May 07, 2024 | 84.74 |
| May 06, 2024 | 82.39 |
| May 03, 2024 | 83.66 |
| May 02, 2024 | 82.39 |
| May 01, 2024 | 82.39 |
| April 30, 2024 | 83.20 |
| April 29, 2024 | 82.84 |
| April 26, 2024 | 82.83 |
| April 25, 2024 | 82.38 |
| April 24, 2024 | 81.57 |
| April 23, 2024 | 83.10 |
| April 22, 2024 | 84.35 |
| April 19, 2024 | 83.99 |
| April 18, 2024 | 86.06 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.643
Minimum
Sep 04 2020
98.83
Maximum
Apr 02 2024
20.81
Average
9.715
Median
Mar 29 2022
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
| Theriva Biologics Inc | 0.1446 |
| Oragenics Inc | 2.223 |
Price to Book Value Related Metrics
| PS Ratio | 2.690 |
| Price to Free Cash Flow | 5.626 |
| Price | 4.72 |
| Earnings Yield | -2.12% |
| Market Cap | 129.48M |
| Operating PE Ratio | 84.38 |